SANTA CLARA, Calif.--(BUSINESS WIRE)--Dec. 20, 2005-- GeneChip(R) Human Mitochondrial Resequencing Array 2.0 Enables Researchers to Identify Genetic Variations Associated with Diseases, Forensics, Population Studies or Stem Cells. Affymetrix Inc. (Nasdaq:AFFX) today announced the launch of the GeneChip(R) Human Mitochondrial Resequencing Array 2.0, enabling researchers to analyze the entire sequence of the mitochondrial genome in a single 48 hour experiment. The new microarray interrogates all 16,500 bases of the human mitochondrial genome with only three polymerase chain reactions (PCR), providing scientists with the most efficient and cost-effective method for detecting variants associated with genetic disease, forensics, population studies or stem cells.
